SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Compass Therapeutics, Inc. CMPX NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Compass Therapeutics, Inc. (CMPX) has 12 identified peers for comparison in the Healthcare sector. Peers include ANAB, AVTE, CGEM, ELVN, FIXX, GLUE and others.

CMPX has a market capitalization of $752.28M, compared to an average peer market cap of $1.13B.

Peers & Similar Companies — CMPX

AnaptysBio, Inc.

$70.22 +2.17% $2.02B

Aerovate Therapeutics, Inc.

$2.68 0.00% $77.68M

Cullinan Oncology, Inc.

$14.35 +0.70% $868.55M

Enliven Therapeutics, Inc.

$44.85 +2.33% $2.68B

Homology Medicines, Inc.

$0.93 +0.77% $3.02M

Monte Rosa Therapeutics, Inc.

$17.50 -0.28% $1.14B

Gossamer Bio, Inc.

$0.43 +7.74% $101.29M

Structure Therapeutics Inc.

$53.19 -1.95% $3.06B

IDEAYA Biosciences, Inc.

$32.35 -1.43% $2.84B

$5.51 +9.98% $286.42M

Kronos Bio, Inc.

$0.88 +1.49% $53.65M

Keros Therapeutics, Inc.

$11.55 +3.59% $429.91M

People Also View

NewAmsterdam Pharma Company N.V.

Structure Therapeutics Inc.

IDEAYA Biosciences, Inc.

Enliven Therapeutics, Inc.

AnaptysBio, Inc.

Tyra Biosciences, Inc.

MoonLake Immunotherapeutics

Monte Rosa Therapeutics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message